157 related articles for article (PubMed ID: 25978317)
1. Interaction of cCMP with the cGK, cAK and MAPK Kinases in Murine Tissues.
Wolfertstetter S; Reinders J; Schwede F; Ruth P; Schinner E; Schlossmann J
PLoS One; 2015; 10(5):e0126057. PubMed ID: 25978317
[TBL] [Abstract][Full Text] [Related]
2. Cyclic cytidine 3',5'-monophosphate (cCMP) signals via cGMP kinase I.
Desch M; Schinner E; Kees F; Hofmann F; Seifert R; Schlossmann J
FEBS Lett; 2010 Sep; 584(18):3979-84. PubMed ID: 20691687
[TBL] [Abstract][Full Text] [Related]
3. cCMP, cUMP, cTMP, cIMP and cXMP as possible second messengers: development of a hypothesis based on studies with soluble guanylyl cyclase α(1)β(1).
Beste KY; Seifert R
Biol Chem; 2013 Feb; 394(2):261-70. PubMed ID: 23087103
[TBL] [Abstract][Full Text] [Related]
4. cCMP and cUMP: emerging second messengers.
Seifert R
Trends Biochem Sci; 2015 Jan; 40(1):8-15. PubMed ID: 25435399
[TBL] [Abstract][Full Text] [Related]
5. Isotype-specific activation of cystic fibrosis transmembrane conductance regulator-chloride channels by cGMP-dependent protein kinase II.
French PJ; Bijman J; Edixhoven M; Vaandrager AB; Scholte BJ; Lohmann SM; Nairn AC; de Jonge HR
J Biol Chem; 1995 Nov; 270(44):26626-31. PubMed ID: 7592887
[TBL] [Abstract][Full Text] [Related]
6. cCMP and cUMP in Apoptosis: Concepts and Methods.
Wolter S; Dittmar F; Seifert R
Handb Exp Pharmacol; 2017; 238():25-47. PubMed ID: 28456891
[TBL] [Abstract][Full Text] [Related]
7. Nucleotidyl cyclase activity of soluble guanylyl cyclase in intact cells.
Bähre H; Danker KY; Stasch JP; Kaever V; Seifert R
Biochem Biophys Res Commun; 2014 Jan; 443(4):1195-9. PubMed ID: 24380860
[TBL] [Abstract][Full Text] [Related]
8. cCMP and cUMP Across the Tree of Life: From cCMP and cUMP Generators to cCMP- and cUMP-Regulated Cell Functions.
Seifert R
Handb Exp Pharmacol; 2017; 238():3-23. PubMed ID: 28181008
[TBL] [Abstract][Full Text] [Related]
9. N4-monobutyryl-cCMP activates PKA RIα and PKA RIIα more potently and with higher efficacy than PKG Iα in vitro but not in vivo.
Wolter S; Dove S; Golombek M; Schwede F; Seifert R
Naunyn Schmiedebergs Arch Pharmacol; 2014 Dec; 387(12):1163-75. PubMed ID: 25192685
[TBL] [Abstract][Full Text] [Related]
10. Autoinhibition and isoform-specific dominant negative inhibition of the type II cGMP-dependent protein kinase.
Taylor MK; Ahmed R; Begley M; Uhler MD
J Biol Chem; 2002 Oct; 277(40):37242-53. PubMed ID: 12093798
[TBL] [Abstract][Full Text] [Related]
11. Soluble adenylyl cyclase accounts for high basal cCMP and cUMP concentrations in HEK293 and B103 cells.
Hasan A; Danker KY; Wolter S; Bähre H; Kaever V; Seifert R
Biochem Biophys Res Commun; 2014 May; 448(2):236-40. PubMed ID: 24792377
[TBL] [Abstract][Full Text] [Related]
12. cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets.
Butt E; Abel K; Krieger M; Palm D; Hoppe V; Hoppe J; Walter U
J Biol Chem; 1994 May; 269(20):14509-17. PubMed ID: 8182057
[TBL] [Abstract][Full Text] [Related]
13. Binding of regulatory subunits of cyclic AMP-dependent protein kinase to cyclic CMP agarose.
Hammerschmidt A; Chatterji B; Zeiser J; Schröder A; Genieser HG; Pich A; Kaever V; Schwede F; Wolter S; Seifert R
PLoS One; 2012; 7(7):e39848. PubMed ID: 22808067
[TBL] [Abstract][Full Text] [Related]
14. Fast and slow cyclic nucleotide-dissociation sites in cAMP-dependent protein kinase are transposed in type Ibeta cGMP-dependent protein kinase.
Reed RB; Sandberg M; Jahnsen T; Lohmann SM; Francis SH; Corbin JD
J Biol Chem; 1996 Jul; 271(29):17570-5. PubMed ID: 8663415
[TBL] [Abstract][Full Text] [Related]
15. Substrate- and kinase-directed regulation of phosphorylation of a cGMP-binding phosphodiesterase by cGMP.
Thomas MK; Francis SH; Corbin JD
J Biol Chem; 1990 Sep; 265(25):14971-8. PubMed ID: 2168396
[TBL] [Abstract][Full Text] [Related]
16. Expression and distribution of cyclic AMP- and cyclic GMP-binding protein kinases in the human vagina- an immunohistochemical study.
Uckert S; Waldkirch ES; Albrecht K; Sonnenberg J; Langnäse K; Richter K; Hedlund P; Kuczyk MA
J Sex Med; 2010 Feb; 7(2 Pt 2):888-95. PubMed ID: 20487500
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cGMP-dependent protein kinase II by its own splice isoform.
Gambaryan S; Palmetshofer A; Glazova M; Smolenski A; Kristjansson GI; Zimmer M; Lohmann SM
Biochem Biophys Res Commun; 2002 May; 293(5):1438-44. PubMed ID: 12054676
[TBL] [Abstract][Full Text] [Related]
18. cGMP produced by NO-sensitive guanylyl cyclase essentially contributes to inflammatory and neuropathic pain by using targets different from cGMP-dependent protein kinase I.
Schmidtko A; Gao W; König P; Heine S; Motterlini R; Ruth P; Schlossmann J; Koesling D; Niederberger E; Tegeder I; Friebe A; Geisslinger G
J Neurosci; 2008 Aug; 28(34):8568-76. PubMed ID: 18716216
[TBL] [Abstract][Full Text] [Related]
19. cGMP-dependent protein kinase type I promotes CREB/CRE-mediated gene expression in neurons of the lateral amygdala.
Paul C; Stratil C; Hofmann F; Kleppisch T
Neurosci Lett; 2010 Apr; 473(2):82-6. PubMed ID: 20171263
[TBL] [Abstract][Full Text] [Related]
20. Identification of cCMP and cUMP Substrate Proteins and Cross Talk Between cNMPs.
Schlossmann J; Wolfertstetter S
Handb Exp Pharmacol; 2017; 238():149-167. PubMed ID: 26721673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
